$CRON 90 DAYS STOCK PRICE FORECAST

Stock Price

About the Company

Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio. Cronos Group's portfolio includes PEACE NATURALS™, a global wellness platform, two adult-use brands, COVE™ and Spinach™, and three hemp-derived CBD brands, Lord Jones™, Happy Dance™ and PEACE+™.

Exchange

NASDAQ

Website

thecronosgroup.com

$57M

Total Revenue

665

Employees

$2B

Market Capitalization

-14.64

Price/Earning ratio

Industry Peers

Name Ticker Market Capitalization (USD M) Revenue (USD M) Price/Book Price/Earning Net Margin (%)
Conversion Labs Inc CVLB 108548 35213 3.74 42.66 7.33
Royalty Pharma plc RPRX 19327 2239 2.87 15.52 43.40
Organon & Co. OGN 8644 7891 -4.46 4.95 22.06
Arvinas Inc ARVN 4342 21 8.14 -26.29 -782.93
Tilray Inc TLRY 3286 513 1.23 -9.74 -71.61
ATAI Life Sciences N.V. ATAI 2545 20 5.35 -11.65 -932.88
Cronos Group Inc CRON 2114 57 1.33 -14.64 -258.59
Usana Health Sciences Inc USNA 1837 1254 4.18 13.23 11.09
Phathom Pharmaceuticals Inc PHAT 1178 7.99 -7.35 None
Fulcrum Therapeutics Inc FULC 925 15 11.21 -12.53 -481.07
Intersect ENT Inc XENT 899 103 21.80 -13.10 -66.55
Phibro Animal Health Corp. PAHC 888 833 3.68 16.16 6.53
Edgewise Therapeutics Inc EWTX 848 2.87 -31.45 None
Pliant Therapeutics Inc PLRX 657 13 2.69 -7.66 -613.56
Cyteir Therapeutics Inc CYT 637 3.42 -22.04 None
Urovant Sciences Ltd UROV 503 -3.65 -3.08 None
Ikena Oncology Inc IKNA 467 10 2.52 -8.53 -551.28
Chromadex Corp CDXC 426 62 10.73 -17.97 -37.51
Rain Therapeutics Inc RAIN 404 413 2.50 -13.27 123.20
Provention Bio Inc PRVB 400 2.68 -3.12 None
Evolus Inc EOLS 321 77 4.24 -2.15 -171.53
Verrica Pharmaceuticals Inc VRCA 316 12 6.41 -8.69 -301.45
Terns Pharmaceuticals Inc TERN 263 1.46 -7.62 None
Adicet Bio Inc ACET 230 9 1.00 -4.09 -603.06
Milestone Pharmaceuticals Inc MIST 222 15 1.25 -7.50 -215.93
Kaleido Biosciences Inc KLDO 222 1 4.94 -2.49 None
LifeMD Inc LFMD 201 64 -28.62 -1.44 -133.55
Kala Pharmaceuticals Inc KALA 187 11 2.42 -1.48 None
Osmotica Pharmaceuticals Plc OSMT 181 190 2.64 -1.95 -47.85
Citius Pharmaceuticals Inc CTXR 177 2.21 -7.70 None
scPharmaceuticals Inc SCPH 162 119 2.38 -5.36 -27.05
Aquestive Therapeutics Inc AQST 146 42 -3.02 -2.27 -152.73
Eton Pharmaceuticals Inc ETON 123 15 6.11 -10.06 -74.52
Odonate Therapeutics Inc ODT 117 1.47 -1.00 None
Eyenovia Inc EYEN 113 6 12.86 -5.77 -324.94
Aerpio Pharmaceuticals Inc ARPO 99 15 2.98 -5.24 -28.77
Opiant Pharmaceuticals Inc OPNT 90 37 2.71 -86.08 -3.06
Natural Alternatives Internati NAII 89 169 1.26 10.07 5.68
VYNE Therapeutics Inc VYNE 72 16 1.08 3.27 -554.66
India Globalization Capital In IGC 67 0 2.39 -7.65 -981.18
Mannatech Inc MTEX 66 158 2.63 10.35 4.22
Acasti Pharma Inc ACST 42 0 1.81 -2.11 -611.47
Shineco Inc TYHT 36 14 1.85 -1.78 -159.60
Assertio Holdings Inc ASRT 33 117 0.45 -0.58 -38.05
Reviva Pharmaceuticals Holding RVPH 30 1.64 -4.74 None
Baudax Bio Inc BXRX 28 1 -11.98 0.84 None
Nabriva Therapeutics Plc NBRV 28 12 0.83 -0.47 -452.55
Bio-Path Holdings Inc BPTH 28 0 1.29 -2.68 18.96
Timber Pharmaceuticals Inc TMBR 26 0 11.39 0.88 -527.55
Trevi Therapeutics Inc TRVI 26 1.67 -0.74 None
Lexaria Bioscience Corp LEXX 25 1 3.49 -6.45 -445.15
Hoth Therapeutics Inc HOTH 22 1.85 -2.29 None
Cyanotech Corp. CYAN 17 34 0.99 13.57 3.83
Sonoma Pharmaceuticals Inc. SNOA 11 17 3.13 -2.04 -31.96

Cronos Group Inc. stock underperforms Thursday when compared to competitors despite daily gains

1d ago, source: MarketWatch

Shares of Cronos Group Inc. inched 0.34% higher to $5.93 Thursday, on what proved to be an all-around mixed trading session ...

Cronos Group Inc. (CRON) Stock Behavior Isn’t As Predictable As You Think

8d ago, source: stocksregister

Cronos Group Inc. (NASDAQ:CRON) at last check was buoying at $6.26 on Thursday, September 09, with a rise of 1.62% from its closing price on previous day. Taking a look at stock we notice that its ...

Cronos Group Inc.: Low Probability and Materiality of ESG Risks Leaves Cronos’ FVE and Uncertainty Rating Intact

5d ago, source: YAHOO!Finance

Find the latest Cronos Group Inc. Common Share (CRON) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance ...

North America CBD Infused Beverages Estimated To Be One of the Largest Sectors in Cannabis Industry Through 2025

7d ago, source: PR Newswire

Active cannabis companies in news today include: CanaFarma Hemp Products Corp. (OTCPK: CNFHF) (CSE: CNFA), Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC), Cronos Group, Inc. (NASDAQ ...

TSX Ends Notably Lower

3d ago, source: Business Insider

Healthcare shares Tilray Inc (TLRY.TO) and Cronos Group (CRON.TO) ended lower by 3.7% and 3.4%, respectively. Organigram Holdings (OGI.TO) ended 2.8% down and Canopy Growth Corp (WEED.TO ...

Biosynthesis of Cannabinoids Market Is Booming Across the Globe Explored in Latest Report 2021-2026

11d ago, source: manometcurrent.com

ResearchMoz has released a new report on the Global Biosynthesis of Cannabinoids market. This report contains essential insights into the market that will help customers make accurate business ...

Canadian Market In Negative Territory In Cautious Trade

3d ago, source: Business Insider

Tilray Inc. (TLRY.TO), down nearly 3% ... is lower by 2.4% and Cronos Group (CRON.TO) is declining 2.2%, while Aurora Cannabis (ACB.TO) and Bausch Health Companies (BHC.TO) are down 2% and ...

Global Cannabis Beverages Market to Reach $2 Billion by 2026

7d ago, source: WFMZ-TV

Companies: 79 - Players covered include Aphria; Aurora Cannabis; CannTrust Holdings, Inc.; Canopy Growth; Cronos Group Inc.; Dixie Brands Inc.; GW Pharmaceuticals plc ...

North America CBD Infused Beverages Estimated To Be One of the Largest Sectors in Cannabis Industry Through 2025

7d ago, source: PR Newswire

FinancialNewsMedia.com News Commentary - Consumers are shifting their preference from soft drinks to wellness drinks leading to the ...

FinancialNewsMedia.com: North America CBD Infused Beverages Estimated To Be One of the Largest Sectors in Cannabis Industry Through 2025

7d ago, source: Finanznachrichten

FinancialNewsMedia.com News Commentary - Consumers are shifting their preference from soft drinks to wellness drinks leading to the increasing ...

Your Portfolio